What Researchers Did
Researchers reviewed clinical studies on hyperbaric oxygen therapy (HBOT) for post-concussion syndrome (PCS) and identified their methodological limitations.
What They Found
Post-concussion syndrome affects 25% of mild traumatic brain injury patients, and while hyperbaric oxygen therapy (HBOT) is effective for acute and severe TBI, its efficacy for PCS is debated. The review identified several limitations in existing HBOT studies for PCS, including inappropriate sham groups (using room air at 1.2 or 1.3 ATA), delayed administration, subjective assessment methods, and small sample sizes.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As an editorial, this review offers critical analysis but does not present new primary data or follow a systematic review methodology.